Abiopharma

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

IsoEnergy Provides Update on Wildfire Activity Near Larocque East Project, Athabasca Basin

ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Sharon AI Announces Closing of US$1.6 Billion Strategic Financing

Commerce Bank to Acquire Nolan & Associates, Adding Investment Banking Capabilities for Middle-Market Clients

OTC Markets Group Welcomes Surge Energy Inc. to OTCQX

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Palantir and Surf Air Mobility Expand Partnership to Accelerate Commercialization of OperatorOS, OwnerOS, and Enterprise Products

Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen